PETS News

Cardone Ventures Announces Unsolicited $4.25 Per Share All-Cash Proposal to Acquire PetMed Express

PETS

MIAMI--(BUSINESS WIRE)--Cardone Ventures, backed by billionaire investor, Grant Cardone and his business partners Brandon and Natalie Dawson, today announced that it has submitted an unsolicited, non-binding proposal to acquire PetMed Express, Inc. (Nasdaq: PETS) (“PetMeds”) for $4.25 per share in cash, representing an implied equity value of approximately $89 million. The proposal was delivered to the Board of Directors of PetMed Express and is not subject to any financing contingency, reflect

December 16, 2025
Read more →

PetMeds Announces Holiday Collection: Wellness-Focused Gifts for Pets and the People Who Love Them

PETS

DELRAY BEACH, Fla., Dec. 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company”), today unveiled its new Holiday Collection, a curated selection of health, wellness, and lifestyle products designed for pet parents who want to give purposeful, practical gifts this season. Unlike traditional pet gifts such as toys or beds, PetMeds’ giftable assortment focuses on products that improve pets’ everyday health, comfort, safety, and happiness, making them ideal for the pet owner who has everything.

December 10, 2025
Read more →

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS

PETS

NEW YORK, Aug. 16, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. ("PetMed" or the "Company") (NASDAQ: PETS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...

August 16, 2025Lawsuits
Read more →

PetMed Express, Inc. Announces Management Changes

PETS

DELRAY BEACH, Fla., Aug. 12, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (the “Company”) dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced that its Chief Executive Officer, Sandra Campos, and Chief Financial Officer, Robyn D’Elia, have resigned from their positions and employment with the Company.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS

PETS

NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

PetMed Express Delays Q4 And FY25 Earnings; To Issue Earnings Release, Hold Call And File Annual Report On 10-K No Later Than June 16, 2025

PETS

June 10, 2025
Read more →

Silvercape Investments Says Intends To Engage In Discussions With PetMed Express' Management And/Or Co's Board; It May Also Discuss Possibility Of Nominating Person To Become Director Of PetMed Express

PETS

May 20, 2025
Read more →

PetMed Express 13G Filing Shows SilverCape Investments Reported A 11.1% Stake In The Co As Of May 18, 2025

PETS

May 20, 2025
Read more →

PetMed Express Partners With Dutch To Provide Accessible Telehealth Services For Pets

PETS

May 7, 2025
Read more →

Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $3.2

PETS

April 17, 2025
Read more →

PetMed Express Q2 2025 GAAP EPS $0.11 Beats $(0.05) Estimate, Sales $59.570M Miss $66.000M Estimate

PETS

November 6, 2024
Read more →